Search Results - Jochen Ittner
- Showing 1 - 4 results of 4
-
1
Antidiabetic PPARγ-Activator Rosiglitazone Reduces MMP-9 Serum Levels in Type 2 Diabetic Patients With Coronary Artery Disease by Nikolaus Marx, Johannes M. Froehlich, Laila Siam, Jochen Ittner, Gerhard Wierse, Arnold Schmidt, Hubert Scharnagl, Vinzenz Hombach, Wolfgang Köenig
Published 2003Artigo -
2
Effect of Rosiglitazone Treatment on Soluble CD40L in Patients With Type 2 Diabetes and Coronary Artery Disease by Nikolaus Marx, Armin Imhof, Johannes M. Froehlich, Laila Siam, Jochen Ittner, Gerhard Wierse, Arnold Schmidt, Winfried Maerz, Vinzenz Hombach, Wolfgang Köenig
Published 2003Artigo -
3
Randomized Trial of Effect of Cyclical Etidronate in the Prevention of Corticosteroid-Induced Bone Loss by Christian Roux, Pasquale Oriente, Roland Laan, Rodney Hughes, Jochen Ittner, Stefan Goemaere, Ombretta Di Munno, Jean Michel Pouillès, S. Horlait, Bernard Cortet for the ciblos study group
Published 1998Artigo -
4
Intravenous Zoledronic Acid in Postmenopausal Women with Low Bone Mineral Density by Ian R. Reid, Jacques P. Brown, P. Burckhardt, Zebulun D. Horowitz, Peter Richardson, U. Trechsel, A. Widmer, J.-P. Devogelaer, Jean‐Marc Kaufman, Philippe Jaeger, Jean-Jacques Body, Maria Luisa Brandi, Johann Broell, Raffaele Di Micco, Andrea Riccardo Genazzani, Dieter Felsenberg, J. Happ, Michael Hooper, Jochen Ittner, G. Leb, Hans Mallmin, Timothy M. Murray, S. Ortolani, Alessandro Rubinacci, Maria Sääf, Göran Samsioe, Leon Verbruggen, Pierre J. Meunier
Published 2002Artigo
Search Tools:
Related Subjects
Internal medicine
Medicine
Alternative medicine
Pathology
Placebo
Bone density
Bone mineral
Coronary artery disease
Diabetes mellitus
Endocrinology
Femoral neck
Osteoporosis
Rosiglitazone
Surgery
Type 2 diabetes
Urology
Activator (genetics)
Bisphosphonate
Bone remodeling
Cardiology
Corticosteroid
Dosing
Etidronic acid
Gastroenterology
Insulin
Interquartile range
Matrix metalloproteinase
Peroxisome proliferator-activated receptor
Pioglitazone
Randomized controlled trial